Myers M G, Hope-Gill H F
Clin Pharmacol Ther. 1979 Mar;25(3):303-8. doi: 10.1002/cpt1979253303.
The effect of intravenous d- and dl-propranolol on serum insulin levels has been examined before and after the administration of glucose orally to 10 normal subjects. The increase in serum insulin 45 to 90 min after glucose ingestion was reduced during the infusion of either d- or dl-propranolol. The insulin suppression was not accompanied by any alteration in the glucose curves. The insulin/glucose ratios were reduced by both d- and dl-propranolol during the time of maximum glucose and insulin responses. Neither d- nor dl-propranolol induced any significant change in basal glucose or insulin levels before glucose administration. Since d-propranolol has no appreciable beta adrenoceptor blocking activity, it appears that the suppression of glucose-stimulated insulin release by propranolol may be due primarily to local anesthetic properties which are exerted equally by both isomers.
已对10名正常受试者口服葡萄糖前后静脉注射d-和dl-普萘洛尔对血清胰岛素水平的影响进行了研究。在输注d-或dl-普萘洛尔期间,葡萄糖摄入后45至90分钟血清胰岛素的增加减少。胰岛素抑制并未伴随葡萄糖曲线的任何改变。在葡萄糖和胰岛素反应最大时,d-和dl-普萘洛尔均使胰岛素/葡萄糖比值降低。在给予葡萄糖之前,d-和dl-普萘洛尔均未引起基础葡萄糖或胰岛素水平的任何显著变化。由于d-普萘洛尔没有明显的β肾上腺素受体阻断活性,因此普萘洛尔对葡萄糖刺激的胰岛素释放的抑制作用可能主要归因于局部麻醉特性,两种异构体均具有相同的作用。